Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-12-15

FDA Approved: TARPEYO — Original Application (Calliditas Therapeutics AB)

View source ↗

Summary

FDA approved Tarpeyo (budesonide) from Calliditas Therapeutics AB through an original application for the treatment of IgA nephropathy. This marks the formal re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tarpeyo (budesonide)

Snippet

ORIG AP for TARPEYO (BUDESONIDE)